Cargando…
Glucocorticoids and COVID-19
Coronavirus Disease 19 (COVID-19) is associated with high morbidity and mortality rates globally, representing the greatest health and economic challenge today. Several drugs are currently approved for the treatment of COVID-19. Among these, glucocorticoids (GCs) have received particular attention d...
Autores principales: | Bruscoli, Stefano, Puzzovio, Pier Giorgio, Zaimi, Maria, Tiligada, Katerina, Levi-Schaffer, Francesca, Riccardi, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556882/ https://www.ncbi.nlm.nih.gov/pubmed/36243331 http://dx.doi.org/10.1016/j.phrs.2022.106511 |
Ejemplares similares
-
Latest Progresses in Allergic Diseases Biomarkers: Asthma and Atopic Dermatitis
por: Puzzovio, Pier Giorgio, et al.
Publicado: (2021) -
Glucocorticoids, Sex Hormones, and Immunity
por: Bereshchenko, Oxana, et al.
Publicado: (2018) -
Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice
por: Bruscoli, Stefano, et al.
Publicado: (2021) -
Glucocorticoid-Induced Leucine Zipper: A Novel Anti-inflammatory Molecule
por: Bereshchenko, Oxana, et al.
Publicado: (2019) -
Histamine receptors and COVID-19
por: Ennis, Madeleine, et al.
Publicado: (2020)